All Type of News
Celebrex generics’ counterattacks have begun
Having difficult times last year, Celebrex generics attracted attention of the industry as newly landed in university hospitals.
According to the industry concerned on the 28th, Severance Hospital has newly approved ...
Minister Jin-yup Jung, “We will make the Medical Law amendment passed for telemedicine”
The Ministry of Health and Welfare has again stressed a will to pass the amendment to the Medical Law for the enforcement of telemedicine.
Minister Jin-yup Jung of Health and Welfare resolved the medical industry’s m...
Laboratorios Cinfa strengthens marketing campaign of ‘Farmalastic’ on pharmacies
Laboratorios Cinfa Korea(CEO Joo-choel Lee), a Spanish pharmaceutical company, will strengthen its marketing campaign over a medical device brand, ‘Farmalastic,’ on pharmacies.
Laboratorios Cinfa, consisting of appro...
Pharmaceutical and distribution companies have difficulties in securing middle-grade sales personnel
While the importance of salesmen has been amplified due to the fierce sales competition, pharmaceutical companies and pharmaceutical wholesalers have had difficulties in securing middle-grade salesmen. The phenomenon ...
Will President Kyung-ho Lee be reappointed to the KPMA head?
President Kyung-ho Lee, who has served as the head of the Korea Pharmaceutical Manufacturers Association(KPMA) since July 2010, has attracted attention whether he could be reappointed.
According to the KPMA and the p...
Will ‘Zemiglo’ handed to Daewoong change dynamics of the DPP-4 market?
As the domestic sales license of ‘Zemiglo,’ a domestic diabetes treatment which has been a hot potato since the beginning of this year, was passed to Daewoong Pharmaceutical, its future dynamic is expected to change.
...
President Heng-myung Lee of Myung In Pharm as powerful candidate of next pharmaceutical association president
President Heng-myung Lee of Myung In Pharm has been mentioned as the most powerful candidate for the next president of the Korea Pharmaceutical Manufacturers Association(KPMA).
The KPMA held a board meeting at Palace...
Hanmi is defeated in revocation trial of Viagra’s ‘blue diamond shape’ patentThe Viagra’s blue diamond shape was recognized to be exclusively used by Pfizer.
The 4th Court of the Patent Court announced, on the 25th, the revocation of the exclusive use r...
|
High expectation on ‘Lynparza,’ BRCA-mutated ovarian cancer targeted treatment
‘Lynparza,’ a targeted therapy for ovarian cancer known for its low survival rate and high recurrence rate, was launched in Korea.
On the 26th, AstraZeneca Korea(hereinafter referring to AZ) announced the launch of ‘...
‘Jardiance’ challenges first cardiovascular disease prevention as antidiabetic
‘Jardiance’ challenges to secure the ‘cardiovascular disease prevention’ indication for the first time as a diabetes drug.
According to the industry concerned on the 27th, Boehringer Ingelheim and Lilly turned in app...
